With a small to moderate within cluster correlation (ICC = 0.10) and moderate individual autocorrelation (0.50), this analysis will have adequate power (power = 0.945) to detect an OR of 1.5 in the proportion of participants achieving viral suppression with at least 90 participants per site. Our effect size estimate is conservative given that the iCARE UG3 pilot trial findings (OR = 14.0) was not randomized and not controlled. Findings from our prior randomized trial of text messaging on medication adherence (a related outcome) among YLH in the United States suggested an effect size of OR = 2.12 (95% CI 1.01–4.45).
Primary study data will be analyzed as soon as possible after the end of data collection, with study findings disseminated in peer-review public health journals.
Copyright and License information: ©2023 Joel Msafiri FrancisThis is an open access article distributed under the terms of the , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ©2023 Joel Msafiri FrancisThis is an open access article distributed under the terms of the , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ©2023 Joel Msafiri FrancisThis is an open access article distributed under the terms of the , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.